comparemela.com
Home
Live Updates
Pharmagenesis Cardiff - Breaking News
Pages:
Pharmagenesis Cardiff News Today : Breaking News, Live Updates & Top Stories | Vimarsana
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens.
United states
United kingdom
University of chicago
Eteläuomen läi
Eli lilly
Vifor pharma
Pharmagenesis cardiff
Georgel bakris
Boehringer ingelheim
American heart association comprehensive hypertension center
Novo nordisk
International conference on harmonization
Department of medicine
American heart association scientific sessions
Study group
Group information
vimarsana © 2020. All Rights Reserved.